Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients

A prospective, multicentre, phase IIIb study with an exploratory, open-label design was conducted to evaluate efficacy and safety of anidulafungin for the treatment of candidaemia/invasive candidiasis (C/IC) in specific ICU patient populations. Adult ICU patients with confirmed C/IC meeting ≥1 of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruhnke, M, Paiva, J A, Meersseman, W, Pachl, J, Grigoras, I, Sganga, G, Menichetti, F, Montravers, P, Auzinger, G, Dimopoulos, G, Borges Sá, M, Miller, P J, Marček, T, Kantecki, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Mycology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510306/
https://www.ncbi.nlm.nih.gov/pubmed/22404732
http://dx.doi.org/10.1111/j.1469-0691.2012.03784.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510306/
https://www.ncbi.nlm.nih.gov/pubmed/22404732
http://dx.doi.org/10.1111/j.1469-0691.2012.03784.x

Ejemplares similares